Multiple Sclerosis Treatment Options: Disease‑Modifying and Symptomatic Therapies

There is no cure for MS, but a growing arsenal of treatments modifies disease course and manages symptoms.

Disease‑Modifying Therapies (DMTs)

  • Injectables: Interferon beta‑1a/1b, glatiramer acetate.
  • Oral: Fingolimod, dimethyl fumarate, teriflunomide, siponimod, cladribine, ozanimod, ponesimod.
  • Infusion/Monoclonal antibodies: Natalizumab, ocrelizumab, ofatumumab, alemtuzumab, ublituximab.
  • Emerging: BTK inhibitors (tolebrutinib), CAR‑T, remyelination agents.

Symptomatic Management

  • Spasticity: Baclofen, tizanidine, botulinum toxin.
  • Fatigue: Amantadine, modafinil, energy conservation.
  • Neuropathic pain: Gabapentin, pregabalin, duloxetine.
  • Bladder: Anticholinergics, beta‑3 agonists, botox, catheterization.
  • Depression/anxiety: SSRIs, SNRIs, CBT.

Rehabilitation & Lifestyle

  • Physical/occupational/speech therapy.
  • Exercise (aerobic, resistance, balance).
  • Vitamin D supplementation, smoking cessation, healthy diet.
  • Complementary: yoga, mindfulness, acupuncture (adjunctive).

Treatment is highly individualized; shared decision‑making with an MS specialist is essential.

Multiple Sclerosis - Related Articles